The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
Pretty Garg, Fabian Maass, Sivaraj Mohana Sundaram, Brit Mollenhauer, Sameehan Mahajani, Christoph van Riesen, Sebastian Kügler, Mathias Bähr
Topics & Concepts
BiomarkerAutoantibodyParkinson's diseaseDiseaseAlpha-synucleinCohortClinical significanceInternal medicineSynucleinImmunologyMedicineOncologyBiologyAntibodyGeneticsParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBotulinum Toxin and Related Neurological Disorders